“The Characteristics of Cardiovascular Adverse Events in Therapy With Immune Checkpoint Inhibitors: The Result of Work of the Multi-Disciplinary Team”. Voprosy Onkologii, vol. 70, no. 3, July 2024, pp. 541-9, https://doi.org/10.37469/0507-3758-2024-70-3-541-549.